Avalon’s CEO Bill Kerr, M.D., shares in a MedCity News article why lab testing price transparency and payment integrity programs should be priorities as the U.S. healthcare industry
continues to advance value-based care and population health.
Read more by visiting MedCityNews.
![bill kerr headshot](https://avalonhcs.com/wp-content/uploads/2022/05/bill-kerr-headshot-scaled-e1653586603825-884x1024.jpeg)